Skip to main content

Banque Cantonale Vaudoise

SEC CIK
0001793755
Latest filing
Jul 31, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Banque Cantonale Vaudoise, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of ABT by Banque Cantonale Vaudoise, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−78,755−100.0%Sold outHolders
Q1 202678,755$8.09M0.3%−17,597−18.3%ReducedHolders
Q4 202596,352$12.1M0.4%+5,753+6.3%AddedHolders
Q3 202590,599$12.1M0.5%−3,863−4.1%ReducedHolders
Q2 202594,462$12.8M0.5%+5,817+6.6%AddedHolders
Q1 202588,645$11.8M0.5%–No prior filingHolders
Q4 2024––––Not filedHolders
Q3 202493,360$10.6M0.4%+59,199+173.3%AddedHolders
Q2 202434,161$3.55M0.1%−60,916−64.1%ReducedHolders
Q1 202495,077$10.8M0.4%+3,760+4.1%AddedHolders
Q4 202391,317$10.1M0.4%−39,062−30.0%ReducedHolders
Q3 2023130,379$12.6M0.6%−1,795−1.4%ReducedHolders
Q2 2023132,174$14.4M0.7%+4,216+3.3%AddedHolders
Q1 2023127,958$13.0M0.6%+4,615+3.7%AddedHolders
Q4 2022123,343$13.5M0.7%+871+0.7%AddedHolders
Q3 2022122,472$11.8M0.7%−145−0.1%ReducedHolders
Q2 2022122,617$13.3M0.7%+20,054+19.6%AddedHolders
Q1 2022102,563$12.1M0.5%−859−0.8%ReducedHolders
Q4 2021103,422$14.6M0.6%−8,694−7.8%ReducedHolders
Q3 2021112,116$13.2M0.6%+58,711+109.9%AddedHolders
Q2 202153,405$6.19M0.3%−17,074−24.2%ReducedHolders
Q1 202170,479$8.45M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.